Technical Analysis for LUMO - Lumos Pharma, Inc.

Grade Last Price % Change Price Change
F 12.435 3.63% 0.44
LUMO closed up 1.78 percent on Wednesday, April 21, 2021, on 36 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up
Historical LUMO trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 3.63%
20 DMA Resistance Bearish 5.47%
Shooting Star Candlestick Bearish 5.47%
180 Bearish Setup Bearish Swing Setup 6.92%
1,2,3 Retracement Bearish Bearish Swing Setup 3.02%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.02%
Pocket Pivot Bullish Swing Setup 3.02%
Outside Day Range Expansion 3.02%
Up 3 Days in a Row Strength 3.02%
Up 4 Days in a Row Strength 3.02%
Older End-of-Day Signals for LUMO ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Support about 5 hours ago
60 Minute Opening Range Breakout about 5 hours ago
Up 3% about 5 hours ago
Rose Above 20 DMA about 6 hours ago
Rose Above Previous Day's High about 6 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Lumos Pharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for severe, rare, and genetic diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone stimulating small molecule, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency. The company has a licensing agreement with Ellipses Pharma Limited for the development of and rights to commercialize nanoparticle formulations of two therapeutics for oncology indications. Lumos Pharma, Inc. was founded in 2011 and is headquartered in Austin, Texas.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Genetic Disease Genetic Diseases Growth Hormone Growth Hormone Deficiency Growth Hormone Therapy

Is LUMO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 36.72
52 Week Low 8.76
Average Volume 65,809
200-Day Moving Average 16.02
50-Day Moving Average 13.68
20-Day Moving Average 12.02
10-Day Moving Average 11.66
Average True Range 0.82
ADX 28.15
+DI 16.20
-DI 24.05
Chandelier Exit (Long, 3 ATRs ) 11.99
Chandelier Exit (Short, 3 ATRs ) 13.16
Upper Bollinger Band 13.25
Lower Bollinger Band 10.79
Percent B (%b) 0.49
BandWidth 20.48
MACD Line -0.56
MACD Signal Line -0.72
MACD Histogram 0.1541
Fundamentals Value
Market Cap 99.56 Million
Num Shares 8.3 Million
EPS -10.37
Price-to-Earnings (P/E) Ratio -1.16
Price-to-Sales 118.05
Price-to-Book 1.12
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.87
Resistance 3 (R3) 12.82 12.48 12.72
Resistance 2 (R2) 12.48 12.26 12.50 12.68
Resistance 1 (R1) 12.24 12.12 12.36 12.29 12.63
Pivot Point 11.90 11.90 11.96 11.92 11.90
Support 1 (S1) 11.66 11.68 11.78 11.71 11.37
Support 2 (S2) 11.32 11.54 11.35 11.32
Support 3 (S3) 11.08 11.32 11.28
Support 4 (S4) 11.13